Related Experiment Video
Updated: Mar 19, 2026
09:38
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
2.6K
Metabolic rewiring in melanoma
B I Ratnikov1, D A Scott1, A L Osterman1
1Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla CA, USA.
Oncogene
|June 9, 2016
Summary
Cancer cells rewire metabolism to survive in tumors. Melanoma
Area of Science:
- Oncology
- Cancer Metabolism
- Molecular Biology
Background:
- Cancer cells adapt to tumor microenvironments via metabolic rewiring.
- Aerobic glycolysis and glutamine metabolism are key adaptations.
- Specific genetic alterations dictate metabolic profiles in cancers.
Purpose of the Study:
- To discuss metabolic alterations in melanoma development.
- To explore how these metabolic changes affect therapy response.
Main Methods:
- Review of oncogene-driven metabolic rewiring.
- Focus on Mitogen-Activated Protein Kinase (MAPK) pathway in melanoma.
- Analysis of factors controlling central carbon metabolism balance.
Main Results:
- Melanoma exhibits specific metabolic alterations driven by MAPK pathway activation (BRAF/NRAS).
- Factors like HIF1α, Myc, and MITF influence metabolic balance.
- Metabolic rewiring is crucial for melanoma proliferation and therapeutic response.
Conclusions:
- Metabolic alterations are fundamental to melanoma pathogenesis.
- Understanding these metabolic changes is vital for developing effective melanoma therapies.
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
02:53Adaptive Mechanisms in Cancer Cells
4.2K
4.2K
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
03:03mTOR Signaling and Cancer Progression
1.6K
1.6K
01:14Introduction to Nuclear Reprogramming
2.4K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.4K